GB1118606A - Compositions for the treatment of haemorrhoids - Google Patents

Compositions for the treatment of haemorrhoids

Info

Publication number
GB1118606A
GB1118606A GB1468666A GB1468666A GB1118606A GB 1118606 A GB1118606 A GB 1118606A GB 1468666 A GB1468666 A GB 1468666A GB 1468666 A GB1468666 A GB 1468666A GB 1118606 A GB1118606 A GB 1118606A
Authority
GB
United Kingdom
Prior art keywords
compositions
haemorrhoids
vitamin
treatment
muton
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1468666A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NADIA MUTON
Original Assignee
NADIA MUTON
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NADIA MUTON filed Critical NADIA MUTON
Priority to GB1468666A priority Critical patent/GB1118606A/en
Publication of GB1118606A publication Critical patent/GB1118606A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

1.118,606. Compositions for treating haemorrhoids. E. H. MUTON and N. MUTON. 21 June, 1967 [1 April, 1966], No. 14686/66. Heading A5B. Compositions for oral administration (e.g. as pills or capsules) in the treatment of haemorrhoids comprise, per unit dose, 10 grains of assimilable calcium compound (calcium gluconate or calcium glycerophosphate), 300 mg. of vitamin B as in dried yeast, 200 mg. of vitamin C, 1 gm. of piperazine phosphate and 1000 I.U. of vitamin D.
GB1468666A 1966-04-01 1966-04-01 Compositions for the treatment of haemorrhoids Expired GB1118606A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1468666A GB1118606A (en) 1966-04-01 1966-04-01 Compositions for the treatment of haemorrhoids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1468666A GB1118606A (en) 1966-04-01 1966-04-01 Compositions for the treatment of haemorrhoids

Publications (1)

Publication Number Publication Date
GB1118606A true GB1118606A (en) 1968-07-03

Family

ID=10045756

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1468666A Expired GB1118606A (en) 1966-04-01 1966-04-01 Compositions for the treatment of haemorrhoids

Country Status (1)

Country Link
GB (1) GB1118606A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031130A2 (en) * 1995-04-07 1996-10-10 Abbott Laboratories Calcium supplements and calcium containing beverages comprising vitamin d
US5597595A (en) * 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5609897A (en) * 1995-04-07 1997-03-11 Abbott Laboratories Powdered beverage concentrate or additive fortified with calcium and vitamin D
US5770254A (en) * 1994-10-21 1998-06-23 Healthy Foods Solutions, Inc. Reduced-fat compositions and methods for preparing and using same
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770254A (en) * 1994-10-21 1998-06-23 Healthy Foods Solutions, Inc. Reduced-fat compositions and methods for preparing and using same
WO1996031130A2 (en) * 1995-04-07 1996-10-10 Abbott Laboratories Calcium supplements and calcium containing beverages comprising vitamin d
WO1996031130A3 (en) * 1995-04-07 1997-01-03 Abbott Lab Calcium supplements and calcium containing beverages comprising vitamin d
US5597595A (en) * 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5609897A (en) * 1995-04-07 1997-03-11 Abbott Laboratories Powdered beverage concentrate or additive fortified with calcium and vitamin D
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage

Similar Documents

Publication Publication Date Title
IL36299A0 (en) 3-octadecyloxypropyl-2'-trimethylammoniumethyl phosphate,its preparation and pharmaceutical compositions containing it
AU463957B2 (en) Piperazine derivatives, processes for their preparation and pharmaceutical compositions containing thesame
ES425514A1 (en) Coumarin derivatives for the treatment of allergies
GB1118606A (en) Compositions for the treatment of haemorrhoids
JPS57150618A (en) Anticancer
GB1421229A (en) Pharmaceutical compositions comprising ergot alkaloid and vitamins
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
GB1424611A (en) Pharmaceutical compositions
AU464013B2 (en) Derivatives of 1,2,3,4-tetrahydropyrimidine processes for their preparation, and compositions incorporation them
GB1321466A (en) N-acetyl-6-amino-hexanoic acid derivative process for its production and pharmaceutical compositions containing the derivative
IE35419L (en) Pharmaceutical composition containing cyclobenzaprine
GB1300486A (en) Compositions for the treatment of respiratory ailments in man
IE36780B1 (en) New pharmaceutical preparations
GB1449043A (en) Treatment of asthma
IL43761A0 (en) Tetrazole derivatives of chromonyloxy-phenoxypropanes,their preparation and pharmaceutical compositions containing them
PH10103A (en) 1)aryl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin 2-ones derivatives,its pharmaceutical composition and process of preparation
CA987591A (en) Bronchodilatory compositions containing quinazoline derivatives for inhalation therapy
GB1289039A (en)
CA945544A (en) 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS
GB1446829A (en) Pharmaceutical compositions
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
IL37609A (en) Ethers of 1-hydroxyalkyl-5-phenyl-1,3-dihydro-2h-1,4 benzodiazepin-2-ones,processes for their preparation and pharmaceutical compositions containing the same
IL38865A0 (en) Penicilloic acid derivatives,their manufacture and pharmaceutical compositions containing them
GB1264695A (en)
GB1446615A (en) Pharmaceutical compositions containing an anti-allergy drug